Navigation Links
Pharmacyclics Announces Preclinical Results Supporting Development of Its Novel Btk Inhibitor in Immune Mediated Diseases
Date:4/14/2008

SAN DIEGO and SUNNYVALE, Calif., April 14 /PRNewswire-FirstCall/ -- Pharmacyclics, Inc. (Nasdaq: PCYC) today presented results from its preclinical program evaluating PCI-32765, an orally available, selective inhibitor of Bruton's tyrosine kinase, or Btk, in B-cell receptor (BCR) modulated diseases such as lymphomas and autoimmune diseases. The data were presented during the Annual Meeting of the American Association for Cancer Research (AACR) being held this week in San Diego, CA.

Researchers conducted studies with PCI-32765 examining the downstream signaling events in the BCR signal transduction pathways. In vitro drug treatment of B-cell lymphomas blocked BCR mediated signaling and in vivo drug treatment of lymphoma-bearing animal models resulted in inhibition of tumor growth. Normal human B-cell activation was also shown to be inhibited by drug treatment in vitro. PCI-32765 also showed significant activity in animal models of arthritis.

"These studies highlight the importance of Btk in immune mediated diseases," said Joseph J. Buggy, Ph.D., vice president of research for Pharmacyclics. "Further, these data support our ongoing IND-enabling studies for PCI-32765, and our plans for an anticipated clinical trial later this year."

B-cells are a type of white blood cell that normally play a key role in the body's immune response. However, when B-cells are overactive, the immune system produces inflammatory cells and antibodies that begin to attack the body's own tissue, leading to autoimmune diseases such as rheumatoid arthritis. Most lymphomas are caused by uncontrolled growth of B-cells. Btk is an enzyme that plays a crucial role in B-cell activation and inhibition of its function may be useful in the treatment of imm
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Pharmacyclics Announces Data and Publication Characterizing Highly-Selective HDAC Inhibitor
2. HUYA Bioscience Intl Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China - HBI-8000, Promising New Cancer Compound
3. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
4. Perrigo Announces Approval for Over-the-Counter Childrens Cetirizine Oral Solution
5. Nuvelo Announces Preclinical Data for NU206 Demonstrating Potent Therapeutic Activity in Oral Mucositis Models
6. Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
7. Antipodean Pharmaceuticals Announces Completion of Phase 2 Study of Lead Compound MitoQ(R)
8. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007
9. Poniard Pharmaceuticals Announces Presentation of Clinical Data From Picoplatin Phase 2 Small Cell Lung Cancer Trial to be Presented at 1st IASLC-ESMO European Lung Cancer Conference
10. Intra-Cellular Therapies Announces the Discovery of Potent Antidepressant Activity in ITI-007/ITI-722
11. Favrille Announces Data Cutoff for Phase 3 Registration Trial of Specifid; Data Analysis and Unblinding Expected in June
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... SHENYANG, CHINA , May 24, 2013 /PRNewswire/ ... ("3SBio" or the "Company"), a leading ... developing, manufacturing and marketing biopharmaceutical products, announced today ... (the "EGM"), the Company,s shareholders voted in favor ... previously announced agreement and plan of merger dated ...
(Date:5/23/2013)... Amgen (NASDAQ: AMGN ) will present ... on Thursday, May 30, 2013, at the Westin Boston Waterfront ... Eastern Daylight Time. Arvind Sood , vice ... conference. Live audio of the presentation can be accessed from ... Investors. A replay of the webcast will also be available ...
(Date:5/23/2013)...  MGC Diagnostics Corporation (NASDAQ: MGCD ) ... scheduled a conference call to discuss its financial results ... April 30, 2013. The call will be at 4:30 ... will report financial results for the second quarter of ... May 30, 2013. (Logo: http://photos.prnewswire.com/prnh/20120821/LA60189LOGO ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3MGC Diagnostics Corporation to Report Second Quarter Fiscal 2013 Financial Results on Thursday, May 30, 2013 2
... to FDA for Stand-Alone Therapy in Q1 2008, ... AMLN ) and Eli Lilly and Company (NYSE: ... patients with type 2 diabetes who were,unable to achieve ... with either monotherapy (stand-alone) BYETTA(R) (exenatide),injection taken twice daily ...
... - "ADVANCE Results go Beyond Existing Evidence", ... study of diabetes treatments,show that intensive blood glucose ... as required, protects patients against serious,complications of the ... kidney disease by one-fifth. Presented today at the ...
Cached Medicine Technology:Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 2Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 3Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 4Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 5Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 6Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss 7The Largest Ever Study of Diabetes Shows Intensive Glucose Control Reduces Serious Complications 2
(Date:5/24/2013)... (PRWEB) May 24, 2013 With Memorial Day ... Amica Insurance is offering tips to help prevent ... National Fire Protection Association (NFPA) reports that gas grills ... and 2010. Charcoal or other solid-fueled grills, meanwhile, caused approximately ... As a result, Amica Insurance is sharing the following tips ...
(Date:5/24/2013)... 2013 Gift Card Network members ... in sustainable card material, are combining forces to ... as a sustainable gift card substrate. , The ... challenges and increase education and usage of these ... the reduction of carbon footprint and environmental impact ...
(Date:5/24/2013)... 2013 Area homeowners dreaming about owning a ... tubs to choose from at factory-direct pricing during the ... event takes place at Emerald Pool and Patio ... Jacuzzi, the industry's leading hot tub brand, scheduled the event ... The event will feature popular hot tub models at up ...
(Date:5/24/2013)... May 24, 2013 Dwell Media ... Brandon Huff as Executive Vice President of Digital for ... units, which represented a large portion of Yahoo's global ... as Dwell develops a fully-integrated commerce unit to launch ... experience monetizing digital content for leading firms in Silicon ...
(Date:5/24/2013)... 6Webs.com has educated thousands of buyers on ... security monitoring provider. The easy to read reviews ... consumers prefer for unbiased and impartial home security reviews. ... leading wireless home security system providers in the nation. ... number of key factors including reliability, technology and equipment. ...
Breaking Medicine News(10 mins):Health News:Don’t Get Burned: Five Grilling Tips from Amica Insurance 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 2Health News:Making Gift Cards Greener- Competitors Combine Efforts to Educate and Empower Merchants 3Health News:Truckload of Jacuzzi® Hot Tubs Rolls into Bend, Oregon on May 24, 2013 for Sales Event 2Health News:Yahoo Commerce Head Joins Leadership at Dwell Media 2Health News:2013 Best Wireless Security System Providers Reported by 6Webs.com 2
... one side of their visual field benefit from presentation ... sounds for an hour, their visual detection of light ... improved significantly. Neural pathways that simultaneously process information from ... embarked on a whole new therapy approach" says PD ...
... , TUESDAY, May 29 (HealthDay News) -- If you want ... laughing, say researchers who have found that centenarians are often ... perspective. The findings stem from the Longevity Genes Project, ... York City. All the participants in the latest study were ...
... May 30 (HealthDay News) -- Even after they shed their ... "anti-fat prejudice," according to a new study. Researchers asked ... either lost 70 pounds of excess weight or had stayed ... or currently thin. The participants were then asked about ...
... 13 for SLEEP 2012, the premier event for sleep ... with the best clinical practices. SLEEP 2012, the 26th ... is being held at the John B. Hynes Veterans Memorial ... exhibition hall focused solely on sleep medicine and sleep research. ...
... HealthDay Reporter , TUESDAY, May 29 (HealthDay News) ... medicine cabinet staples such as aspirin, Motrin and Aleve ... several major forms of skin cancer, a new Danish ... of both prescription and nonprescription NSAIDs on skin cancer ...
... A specific antioxidant supplement may be an effective ... pilot trial from the Stanford University School of Medicine ... with the disorder. The antioxidant, called N-Acetylcysteine, or ... as reducing the children,s repetitive behaviors. The researchers emphasized ...
Cached Medicine News:Health News:Hear to see: New method for the treatment of visual field defects 2Health News:Optimism, Laughter May Bring Long Life 2Health News:Optimism, Laughter May Bring Long Life 3Health News:Once-Obese Women Still Face Stigma, Study Finds 2Health News:SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston 2Health News:Common Painkillers May Help Prevent Skin Cancer: Study 2Health News:Common Painkillers May Help Prevent Skin Cancer: Study 3Health News:Antioxidant shows promise as treatment for certain features of autism, Stanford study finds 2Health News:Antioxidant shows promise as treatment for certain features of autism, Stanford study finds 3
Trio is a portable pipette stand that keeps your Gilson pipettes within easy reach. A great accessory for use in a fume hood....
Inquire...
... Software is easy to ... with any balance. Use the standard method ... weighings, volume, temperature, pressure, etc.) QualiTrace automatically ... of the measurements from the balance to ...
Reservoir, Low Profile, Single Well, Flat Bottom, 90mL Available Sterile...
Medicine Products: